| 1 | (1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide | - | - | - | - | [1] 11 11 💬
|
| 2 | 250 mg CK-2017357 | - | - | - | - | [2] 2 2, 11 💬
|
| 3 | 500 mg CK-2017357 | - | - | - | - | [2] 2 2, 11 💬
|
| 4 | [acetominofene] | - | - | - | - | [2] 11 11, 63 💬
|
| 5 | [ALN-CC5] | - | - | - | - | [2] 11 11, 62 💬
|
| 6 | [ALXN1210] | - | - | - | - | [6] 2 2, 11, 13, 50, 62, 66 💬
|
| 7 | [Amifampridina fosfato] | - | - | - | - | [2] 3 3, 11 💬
|
| 8 | [ARGX-113] | - | - | - | - | [3] 11 11, 35, 63 💬
|
| 9 | [IMVT-1401] | - | - | - | - | [1] 11 11 💬
|
| 10 | [JNJ-80202135] | - | - | - | - | [1] 11 11 💬
|
| 11 | [M281] | - | - | - | - | [3] 11 11, 53, 61 💬
|
| 12 | [N/A] | - | - | - | - | [11] 2 2, 11, 13, 20, 28, 46, 51, 61, 65, 97, 299 💬
|
| 13 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 14 | [REGN3918] | - | - | - | - | [2] 11 11, 62 💬
|
| 15 | [rituximab] | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 11 11, 14 💬
|
| 16 | [RO5333787] | - | - | - | - | [2] 11 11, 13 💬
|
| 17 | [SAR442168] | - | - | - | - | [2] 11 11, 13 💬
|
| 18 | [TAK-079, TSF-021, TSF79] | - | - | - | - | [1] 11 11 💬
|
| 19 | [UCB7665] | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬
| - | - | [2] 11 11, 63 💬
|
| 20 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 21 | Abatacept Injection | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [3] 11 11, 46, 107 💬
|
| 22 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [19] 11 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
|
| 23 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 24 | Acetylcholine | [1] Acetylcholine Acetylcholine | [1] Acetylcholine chloride
Acetylcholine chloride
💬
| [21] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [17] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, Virion - Ebolavirus, Lyssavirus and Morbillivirus, cAMP signaling pathway 💬 | [1] 11 11 💬
|
| 25 | Acotiamide | [1] Acotiamide Acotiamide | - | - | - | [2] 11 11, 51 💬
|
| 26 | Addition of rituximab if recurrence | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 11 11 💬
|
| 27 | ALN-CC5 | - | - | - | - | [4] 11 11, 62, 66, 109 💬
|
| 28 | Aluminium | [1] Aluminium Aluminium | - | - | - | [2] 11 11, 46 💬
|
| 29 | Aluminum hydroxide | [1] Aluminum hydroxide Aluminum hydroxide | [3] Aluminum hydroxide
Aluminum hydroxide
,
Algeldrate
,
Almagate
💬
| - | - | [1] 11 11 💬
|
| 30 | ALXN1210 | - | - | - | - | [7] 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 31 | ALXN1720 | - | - | - | - | [1] 11 11 💬
|
| 32 | ALXN1830 | - | - | - | - | [3] 11 11, 35, 61 💬
|
| 33 | ALXN2050 | - | - | - | - | [3] 11 11, 62, 66 💬
|
| 34 | AMIFAMPRIDINA | - | - | - | - | [2] 3 3, 11 💬
|
| 35 | Amifampridina fosfato | - | - | - | - | [2] 3 3, 11 💬
|
| 36 | Amifampridine | [1] Amifampridine Amifampridine | [2] Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [3] 3 3, 11, 12 💬
|
| 37 | Amifampridine (base) with modified release | [1] Amifampridine Amifampridine | [2] Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 11 11 💬
|
| 38 | Amifampridine Phosphate | [1] Amifampridine Amifampridine | [2] Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [3] 3 3, 11, 12 💬
|
| 39 | Anito-cel | - | - | - | - | [1] 11 11 💬
|
| 40 | Anti-C5 antibody | - | - | - | - | [4] 11 11, 14, 62, 109 💬
|
| 41 | Anti-Thymocyte Globulin | - | - | - | - | [19] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
|
| 42 | Apraclonidine | [1] Apraclonidine Apraclonidine | [2] Apraclonidine hydrochloride
Apraclonidine hydrochloride
,
Apraclonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 43 | Apraclonidine Hcl 0.5% Oph Soln | [1] Apraclonidine Apraclonidine | [2] Apraclonidine hydrochloride
Apraclonidine hydrochloride
,
Apraclonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 44 | ARGX-113 | - | - | - | - | [5] 11 11, 14, 35, 53, 63 💬
|
| 45 | ARGX-113Pharmaceutical Form: Concentrate for solution for infusion | - | - | - | - | [1] 11 11 💬
|
| 46 | Aritinercept | - | - | - | - | [1] 11 11 💬
|
| 47 | ATG (rabbit) | [1] Rabbit Rabbit | - | - | - | [1] 11 11 💬
|
| 48 | Autologous Hematopoietic Stem Cell Transplantation | - | - | - | - | [7] 11 11, 13, 14, 28, 49, 51, 84 💬
|
| 49 | AZA | - | - | - | - | [4] 11 11, 40, 96, 97 💬
|
| 50 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 51 | B-peptide-CRM197 conjugate | - | - | - | - | [1] 11 11 💬
|
| 52 | B007 | - | - | - | - | [3] 11 11, 35, 222 💬
|
| 53 | BAFF-R CART | - | - | - | - | [2] 11 11, 14 💬
|
| 54 | Batoclimab | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬
| - | - | [2] 11 11, 14 💬
|
| 55 | Batoclimab 340 mg SC bi-weekly | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬
| - | - | [1] 11 11 💬
|
| 56 | Batoclimab 340 mg SC weekly | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬
| - | - | [2] 11 11, 14 💬
|
| 57 | Batoclimab 680 mg SC weekly | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬
| - | - | [1] 11 11 💬
|
| 58 | BBR 2778 | - | - | - | - | [2] 11 11, 13 💬
|
| 59 | BELIMUMAB | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [17] 11 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
|
| 60 | Benlysta (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4] 11 11, 49, 53, 222 💬
|
| 61 | BENLYSTA® (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4] 11 11, 63, 66, 222 💬
|
| 62 | Bexsero | - | - | - | - | [4] 11 11, 13, 62, 223 💬
|
| 63 | Blinatumomab | [1] Blinatumomab Blinatumomab | [1] Blinatumomab
Blinatumomab
💬
| [4] CD19 CD19, CD3D, CD3E, CD3G 💬
| [13] B cell receptor signaling pathway B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [4] 11 11, 46, 49, 222 💬
|
| 64 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [19] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
|
| 65 | Bu Zhong Yi Qi Tang | - | - | - | - | [1] 11 11 💬
|
| 66 | CABA-201 | - | - | - | - | [5] 11 11, 13, 35, 49, 51 💬
|
| 67 | Carmustine | [1] Carmustine Carmustine | [1] Carmustine
Carmustine
💬
| - | - | [5] 11 11, 13, 14, 28, 60 💬
|
| 68 | CC-97540 | - | - | - | - | [5] 11 11, 13, 46, 49, 51 💬
|
| 69 | CD19-BCMA Targeted CAR-T Dose 1 | - | - | - | - | [1] 11 11 💬
|
| 70 | CD19-BCMA Targeted CAR-T Dose 2 | - | - | - | - | [1] 11 11 💬
|
| 71 | CD19-CAR-NK Cells Injection | - | - | - | - | [1] 11 11 💬
|
| 72 | CD19-directed humanised afucosylated monoclonal antibody | - | - | - | - | [1] 11 11 💬
|
| 73 | CD19/BCMA-targeted CAR-T cells | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 74 | CD20/BCMA-directed CAR-T cells | - | - | - | - | [4] 11 11, 13, 49, 51 💬
|
| 75 | CELLCEPT | - | - | - | - | [7] 11 11, 13, 42, 43, 49, 222, 223 💬
|
| 76 | CellCept 500 mg | - | - | - | - | [1] 11 11 💬
|
| 77 | CellCept 500 mg film-coated tablets | - | - | - | - | [1] 11 11 💬
|
| 78 | CellCept 500 mg tablets | - | - | - | - | [1] 11 11 💬
|
| 79 | CellCept®500 mg tablets | - | - | - | - | [1] 11 11 💬
|
| 80 | Cemdisiran | [1] Cemdisiran Cemdisiran | - | - | - | [6] 11 11, 15, 62, 66, 109, 223 💬
|
| 81 | CFZ533 | - | - | - | - | [4] 11 11, 46, 49, 53 💬
|
| 82 | Cizutamig | - | - | - | - | [4] 11 11, 46, 49, 97 💬
|
| 83 | CLADRIBINE | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [3] 11 11, 13, 94 💬
|
| 84 | Cladribine High Dose | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 11 11 💬
|
| 85 | Cladribine Low Dose | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 11 11 💬
|
| 86 | Cladrybine | - | - | - | - | [1] 11 11 💬
|
| 87 | Claseprubart | [1] Claseprubart Claseprubart | - | - | - | [2] 11 11, 14 💬
|
| 88 | CNP-106 | - | - | - | - | [1] 11 11 💬
|
| 89 | Combination Product: Claseprubart | [1] Claseprubart Claseprubart | - | - | - | [1] 11 11 💬
|
| 90 | Combination Product: Efgartigimod + Thymectomy | - | - | - | - | [1] 11 11 💬
|
| 91 | Combination Product: Efgartigimod PH20 SC | - | - | - | - | [2] 11 11, 51 💬
|
| 92 | Combination Product: Gefurulimab | [1] Gefurulimab Gefurulimab | [1] Gefurulimab
Gefurulimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬
|
| 93 | Combination Product: Intravenous immunglobulin + Thymectomy | - | - | - | - | [1] 11 11 💬
|
| 94 | Corynebacterium diphtheriae | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬
|
| 95 | CT103A | [1] CT103A CT103A | - | - | - | [4] 11 11, 13, 14, 16 💬
|
| 96 | CT103A cells | [1] CT103A CT103A | - | - | - | [4] 11 11, 13, 14, 16 💬
|
| 97 | CV-MG01 | [1] CV-MG01 CV-MG01 | - | - | - | [1] 11 11 💬
|
| 98 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 99 | Cyclophosphamide and fludarabine | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [4] 11 11, 13, 14, 16 💬
|
| 100 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 101 | Cytarabine | [1] Cytarabine Cytarabine | [2] Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | [8] 11 11, 13, 14, 25, 34, 49, 60, 65 💬
|
| 102 | DAS-001 | - | - | - | - | [1] 11 11 💬
|
| 103 | Decartes-08 | - | - | - | - | [1] 11 11 💬
|
| 104 | Descartes-08 | - | - | - | - | [3] 11 11, 49, 50 💬
|
| 105 | Diagnostic Test: Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation | [2] Acetylcholine Acetylcholine, Neostigmine | [4] Neostigmine bromide
Neostigmine bromide
,
Neostigmine methylsulfate
,
Acetylcholine chloride
,
Neostigmine
💬
| [22] ACHE ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [18] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Glycerophospholipid metabolism, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, Virion - Ebolavirus, Lyssavirus and Morbillivirus, cAMP signaling pathway 💬 | [1] 11 11 💬
|
| 106 | Difenidramina | - | - | - | - | [2] 11 11, 63 💬
|
| 107 | DIFENIDRAMINA CLORIDRATO | - | - | - | - | [3] 11 11, 19, 63 💬
|
| 108 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [12] 11 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
|
| 109 | Diphenhydramine hydrochloride | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 11 11, 49, 222 💬
|
| 110 | Dose level 1 group | - | - | - | - | [1] 11 11 💬
|
| 111 | Dose level 2 group | - | - | - | - | [1] 11 11 💬
|
| 112 | Dose level 3 group | - | - | - | - | [1] 11 11 💬
|
| 113 | Dose level 4 group | - | - | - | - | [1] 11 11 💬
|
| 114 | ECULIZUMAB | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [8] 11 11, 13, 14, 61, 62, 109, 221, 223 💬
|
| 115 | EFALIZUMAB | [1] Efalizumab Efalizumab | [1] Efalizumab
Efalizumab
💬
| [1] ITGAL ITGAL 💬
| [14] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Integrin signaling, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [10] 11 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬
|
| 116 | Efgartigimod | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [8] 11 11, 14, 35, 36, 53, 63, 64, 300 💬
|
| 117 | Efgartigimod + Telitacicept (1-week interval) group | [1] Telitacicept Telitacicept | - | - | - | [1] 11 11 💬
|
| 118 | Efgartigimod + Telitacicept (2-week interval) group | [1] Telitacicept Telitacicept | - | - | - | [1] 11 11 💬
|
| 119 | Efgartigimod administration | - | - | - | - | [1] 11 11 💬
|
| 120 | EFGARTIGIMOD ALFA | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [7] 11 11, 13, 14, 35, 53, 63, 162 💬
|
| 121 | EFGARTIGIMOD ALFACAS Number: 1821402-21-4Current Sponsor code: ARGX-113Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20- | - | - | - | - | [1] 11 11 💬
|
| 122 | Efgartigimod IV | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [3] 11 11, 63, 222 💬
|
| 123 | Efgartigimod IV or Efgartigimod PH20 SC | - | - | - | - | [1] 11 11 💬
|
| 124 | Efgartigimod PH20 SC | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [7] 11 11, 14, 35, 50, 53, 63, 162 💬
|
| 125 | Empasiprubart | [1] Empasiprubart Empasiprubart | [1] Empasiprubart
Empasiprubart
💬
| [1] C2 C2 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 11 11, 14, 50 💬
|
| 126 | Empasiprubart IV | [1] Empasiprubart Empasiprubart | [1] Empasiprubart
Empasiprubart
💬
| [1] C2 C2 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 11 11, 14, 50 💬
|
| 127 | EN101 | - | - | - | - | [1] 11 11 💬
|
| 128 | Ephedrine | [1] Ephedrine Ephedrine | [3] Ephedrine
Ephedrine
,
Ephedrine hydrochloride
,
Ephedrine sulfate
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 129 | EPHEDRINE HYDROCHLORIDE | [1] Ephedrine Ephedrine | [3] Ephedrine
Ephedrine
,
Ephedrine hydrochloride
,
Ephedrine sulfate
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 130 | Etomidate | [1] Etomidate Etomidate | [1] Etomidate
Etomidate
💬
| [1] GABRA1 GABRA1 💬
| [8] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬 | [2] 6 6, 11 💬
|
| 131 | Etoposide | [1] Etoposide Etoposide | [2] Etoposide
Etoposide
,
Etoposide phosphate
💬
| - | - | [12] 11 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
|
| 132 | EVM18001 Injection | - | - | - | - | [3] 11 11, 49, 51 💬
|
| 133 | Famciclovir | [1] Famciclovir Famciclovir | [1] Famciclovir
Famciclovir
💬
| - | - | [2] 11 11, 13 💬
|
| 134 | Fc- and CDR-modified humanised monoclonal antibody against C5 | - | - | - | - | [3] 11 11, 62, 109 💬
|
| 135 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | - | - | - | - | [2] 3 3, 11 💬
|
| 136 | Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [30] 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 137 | G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [12] 6 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
|
| 138 | GALANTAMINE | [1] Galantamine Galantamine | [2] Galantamine hydrobromide
Galantamine hydrobromide
,
Galantamine
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [3] 6 6, 11, 127 💬
|
| 139 | GAMUNEX 10% | - | - | - | - | [1] 11 11 💬
|
| 140 | GB-0998 (Intravenous immunoglobulin) | - | - | - | - | [1] 11 11 💬
|
| 141 | GC012F | [1] GC012F GC012F | - | - | - | [6] 11 11, 13, 28, 46, 49, 51 💬
|
| 142 | GC012F injection | [1] GC012F GC012F | - | - | - | [4] 11 11, 28, 49, 51 💬
|
| 143 | Gefurulimab | [1] Gefurulimab Gefurulimab | [1] Gefurulimab
Gefurulimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬
|
| 144 | Genetic: Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms | - | - | - | - | [1] 11 11 💬
|
| 145 | Genetic: YTB323 | - | - | - | - | [1] 11 11 💬
|
| 146 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 147 | Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) | - | - | - | - | [1] 11 11 💬
|
| 148 | GSK1550188 | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 149 | HBI0101 CART | - | - | - | - | [5] 11 11, 13, 46, 49, 51 💬
|
| 150 | HBM9161 Injection (340 mg) | - | - | - | - | [1] 11 11 💬
|
| 151 | HBM9161 Injection (680mg and 340 mg) | - | - | - | - | [1] 11 11 💬
|
| 152 | HBM9161 Injection (680mg) | - | - | - | - | [1] 11 11 💬
|
| 153 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [13] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
|
| 154 | Hidrocloruro de efedrina | [1] Ephedrine Ephedrine | [3] Ephedrine
Ephedrine
,
Ephedrine hydrochloride
,
Ephedrine sulfate
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 155 | HIZENTRA ® | - | - | - | - | [1] 11 11 💬
|
| 156 | HN2301 injection | - | - | - | - | [4] 11 11, 46, 49, 51 💬
|
| 157 | HN2302 Injection | - | - | - | - | [3] 11 11, 49, 51 💬
|
| 158 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | - | - | - | - | [4] 11 11, 14, 63, 65 💬
|
| 159 | Human normal immunoglobulin G (IgG) | - | - | - | - | [1] 11 11 💬
|
| 160 | Humanised VHH-type bispecific antibody against Complement component 5 and serum albumin | - | - | - | - | [1] 11 11 💬
|
| 161 | Humanised VHH-type bispecific antibody that binds to Complement component 5 and serum albumin | - | - | - | - | [1] 11 11 💬
|
| 162 | IGIV-C | - | - | - | - | [1] 11 11 💬
|
| 163 | IM-101 Part A | - | - | - | - | [1] 11 11 💬
|
| 164 | IM-101 Part B | - | - | - | - | [1] 11 11 💬
|
| 165 | Immediate treatment with corticosteroids | - | - | - | - | [1] 11 11 💬
|
| 166 | Immediate-Release Tablets | - | - | - | - | [1] 11 11 💬
|
| 167 | Immune globulin | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 168 | Immune Globulin (Human), 10% Caprylate/Chromatography Purified | - | - | - | - | [1] 11 11 💬
|
| 169 | Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) | - | - | - | - | [1] 11 11 💬
|
| 170 | IMMUNOGLOBULIN G | - | - | - | - | [9] 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
| 171 | IMVT-1401 | - | - | - | - | [2] 11 11, 14 💬
|
| 172 | IMVT-1402 | [1] IMVT-1402 IMVT-1402 | - | - | - | [3] 11 11, 46, 53 💬
|
| 173 | INEBILIZUMAB | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [8] 11 11, 13, 46, 49, 51, 53, 95, 300 💬
|
| 174 | Influenza vaccine | - | - | - | - | [6] 11 11, 13, 46, 51, 84, 97 💬
|
| 175 | Intravenous ImmuneGlobulin | - | - | - | - | [1] 11 11 💬
|
| 176 | Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬
|
| 177 | Iptacopan | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [8] 11 11, 61, 62, 63, 66, 109, 222, 223 💬
|
| 178 | IV efgartigimod | - | - | - | - | [1] 11 11 💬
|
| 179 | IVIG | - | - | - | - | [8] 11 11, 13, 14, 18, 51, 63, 65, 172 💬
|
| 180 | IVIG (Intravenous Immunoglobulin) | - | - | - | - | [2] 11 11, 14 💬
|
| 181 | JNJ-80202135 | - | - | - | - | [5] 11 11, 14, 46, 49, 53 💬
|
| 182 | KITE-363 | - | - | - | - | [5] 11 11, 13, 14, 49, 51 💬
|
| 183 | KYV-101 | [1] KYV-101 KYV-101 | - | - | - | [5] 11 11, 13, 46, 50, 51 💬
|
| 184 | LCAR-AIO T cells | - | - | - | - | [3] 11 11, 13, 49 💬
|
| 185 | Leflunomide | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [14] 11 11, 40, 46, 49, 53, 54, 66, 107, 162, 223, 224, 270, 271, 300 💬
|
| 186 | LVIVO-TaVec400 product | - | - | - | - | [4] 11 11, 13, 49, 300 💬
|
| 187 | Lymphodepleting Conditioning | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 188 | M281 | - | - | - | - | [5] 11 11, 46, 49, 53, 61 💬
|
| 189 | M281 Injection | - | - | - | - | [1] 11 11 💬
|
| 190 | Mabthera | - | - | - | - | [20] 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
|
| 191 | Magnesium | [1] Magnesium Magnesium | - | - | - | [23] 3 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
|
| 192 | Magnesium sulfate | [2] Magnesium Magnesium, Magnesium sulfate | [1] Magnesium sulfate
Magnesium sulfate
💬
| - | - | [4] 11 11, 97, 296, 297 💬
|
| 193 | Melphalan | [1] Melphalan Melphalan | [2] Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | [19] 11 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
|
| 194 | MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬
|
| 195 | MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬
|
| 196 | MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬
|
| 197 | MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬
|
| 198 | MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬
|
| 199 | Menveo | - | - | - | - | [4] 11 11, 13, 62, 223 💬
|
| 200 | Mesna | [1] Coenzyme M Coenzyme M | [1] Mesna
Mesna
💬
| - | - | [12] 11 11, 13, 16, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
| 201 | Mestinon | - | - | - | - | [3] 3 3, 6, 11 💬
|
| 202 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 203 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 204 | Metilprdnisolone | - | - | - | - | [1] 11 11 💬
|
| 205 | METILPREDNISOLONE | - | - | - | - | [5] 11 11, 53, 56, 63, 300 💬
|
| 206 | MONARSEN | [1] Monarsen Monarsen | - | - | - | [1] 11 11 💬
|
| 207 | MTM-H-001 Injection | - | - | - | - | [3] 11 11, 13, 46 💬
|
| 208 | MuSK-CAART | - | - | - | - | [1] 11 11 💬
|
| 209 | Mutagrip | - | - | - | - | [2] 11 11, 13 💬
|
| 210 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 211 | Mycophenolate mofetil (CellCept) | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [3] 11 11, 13, 223 💬
|
| 212 | Mycophenolate mofetil [CellCept] | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 11 11 💬
|
| 213 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [9] 11 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
|
| 214 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO | - | - | - | - | [1] 11 11 💬
|
| 215 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE | [2] Aluminum hydroxide Aluminum hydroxide, Corynebacterium diphtheriae | [3] Aluminum hydroxide
Aluminum hydroxide
,
Algeldrate
,
Almagate
💬
| - | - | [1] 11 11 💬
|
| 216 | Neostigmine | [1] Neostigmine Neostigmine | [3] Neostigmine bromide
Neostigmine bromide
,
Neostigmine methylsulfate
,
Neostigmine
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 11 11 💬
|
| 217 | Nipocalimab | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬
| - | - | [6] 11 11, 14, 46, 49, 53, 61 💬
|
| 218 | Nipocalimab Product Code: JNJ-80202135Pharmaceutical Form: Solution for infusionINN or Proposed INN: NipocalimabCAS Number: 2211985-36-1Current Sponsor code: JNJ-80202135Other descriptive name: M281Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬
| - | - | [1] 11 11 💬
|
| 219 | Nipocalimab SC-LIV | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬
| - | - | [1] 11 11 💬
|
| 220 | NMD670 | - | - | - | - | [3] 3 3, 10, 11 💬
|
| 221 | Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4] 11 11, 13, 46, 49 💬
|
| 222 | Ofatumumab | [1] Ofatumumab Ofatumumab | [1] Ofatumumab
Ofatumumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [6] 11 11, 13, 35, 46, 222, 223 💬
|
| 223 | Oral Corticosteroid Tapering Schedule | - | - | - | - | [1] 11 11 💬
|
| 224 | Other: Blood draw | - | - | - | - | [17] 2 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
|
| 225 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 226 | Other: Blood Sample Draw | - | - | - | - | [1] 11 11 💬
|
| 227 | Other: Cheek swab | - | - | - | - | [2] 11 11, 13 💬
|
| 228 | Other: early use of Ravulizumab | [1] Ravulizumab Ravulizumab | [1] Ravulizumab
Ravulizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬
|
| 229 | Other: Laboratory Biomarker Analysis | - | - | - | - | [22] 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 230 | Other: Patients diagnosed with generalized myasthenia gravis and treated with Rozanolixizumab | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬
| - | - | [1] 11 11 💬
|
| 231 | Other: Withdraw all immunosuppresants | - | - | - | - | [1] 11 11 💬
|
| 232 | Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4 | - | - | - | - | [1] 11 11 💬
|
| 233 | Oxaloacetate | - | - | - | - | [1] 11 11 💬
|
| 234 | PARACETAMOLO | - | - | - | - | [10] 2 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
|
| 235 | Peripheral Blood Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
|
| 236 | PIXANTRONE | [1] Pixantrone Pixantrone | [2] Pixantrone
Pixantrone
,
Pixantrone dimaleate
💬
| - | - | [2] 11 11, 13 💬
|
| 237 | Plasma exchange (PE) | - | - | - | - | [6] 11 11, 13, 64, 66, 221, 223 💬
|
| 238 | Plasmapheresis | - | - | - | - | [4] 11 11, 49, 113, 222 💬
|
| 239 | PLEX | - | - | - | - | [1] 11 11 💬
|
| 240 | Povetacicept | [1] Povetacicept Povetacicept | [1] Povetacicept
Povetacicept
💬
| [1] TNFRSF13B TNFRSF13B 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬 | [5] 11 11, 61, 63, 66, 222 💬
|
| 241 | Pozelimab | [1] Pozelimab Pozelimab | [1] Pozelimab
Pozelimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 11 11, 15, 62 💬
|
| 242 | Pozelimab + Cemdisiran | [2] Cemdisiran Cemdisiran, Pozelimab | [1] Pozelimab
Pozelimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬
|
| 243 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 244 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 245 | Prednisone - Azathioprine | [2] Azathioprine Azathioprine, Prednisone | [3] Azathioprine
Azathioprine
,
Prednisone
,
Azathioprine sodium
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 11 11 💬
|
| 246 | Prednisone alone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 11 11, 66 💬
|
| 247 | Prednisone/Prednisolone | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 11 11, 35 💬
|
| 248 | PRIVIGEN | - | - | - | - | [6] 11 11, 14, 51, 63, 65, 222 💬
|
| 249 | PRN2246 | - | - | - | - | [2] 11 11, 13 💬
|
| 250 | Pyridostigmine | [1] Pyridostigmine Pyridostigmine | [1] Pyridostigmine bromide
Pyridostigmine bromide
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [5] 3 3, 6, 11, 51, 256 💬
|
| 251 | Pyridostigmine Bromide | [1] Pyridostigmine Pyridostigmine | [1] Pyridostigmine bromide
Pyridostigmine bromide
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [5] 3 3, 6, 11, 51, 256 💬
|
| 252 | Pyridostigmine, Prednisone, Tacrolimus | [3] Prednisone Prednisone, Pyridostigmine, Tacrolimus | [4] Tacrolimus
Tacrolimus
,
Prednisone
,
Pyridostigmine bromide
,
Tacrolimus
💬
| [7] ACHE ACHE, NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [37] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 253 | Pyridostigmine, Tacrolimus | [2] Pyridostigmine Pyridostigmine, Tacrolimus | [3] Tacrolimus
Tacrolimus
,
Pyridostigmine bromide
,
Tacrolimus
💬
| [6] ACHE ACHE, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [36] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 254 | QT-019C | - | - | - | - | [5] 11 11, 13, 49, 51, 63 💬
|
| 255 | Rabbit | [1] Rabbit Rabbit | - | - | - | [11] 11 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
|
| 256 | Raptiva 100 mg/ml powder and solvent for solution for injection | - | - | - | - | [9] 11 11, 13, 46, 48, 53, 61, 95, 96, 221 💬
|
| 257 | RAVULIZUMAB | [1] Ravulizumab Ravulizumab | [1] Ravulizumab
Ravulizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [8] 2 2, 11, 13, 50, 62, 66, 109, 224 💬
|
| 258 | RC18 160mg | - | - | - | - | [3] 11 11, 13, 66 💬
|
| 259 | RC18 240 mg | - | - | - | - | [2] 11 11, 53 💬
|
| 260 | RECOMBINANT NEISSERIA | - | - | - | - | [1] 11 11 💬
|
| 261 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE | [1] Aluminium Aluminium | - | - | - | [1] 11 11 💬
|
| 262 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN | - | - | - | - | [1] 11 11 💬
|
| 263 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN | - | - | - | - | [2] 11 11, 13 💬
|
| 264 | REGN3918 | - | - | - | - | [2] 11 11, 62 💬
|
| 265 | Remibrutinib | [1] Remibrutinib Remibrutinib | [1] Remibrutinib
Remibrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [3] 11 11, 13, 53 💬
|
| 266 | Remibrutinib (Blinded) | [1] Remibrutinib Remibrutinib | [1] Remibrutinib
Remibrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2] 11 11, 13 💬
|
| 267 | Remibrutinib (Open Label) | [1] Remibrutinib Remibrutinib | [1] Remibrutinib
Remibrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2] 11 11, 13 💬
|
| 268 | Ripertamab | [1] Ripertamab Ripertamab | - | - | - | [4] 11 11, 14, 63, 222 💬
|
| 269 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 270 | Rituximab (Rituxan) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 11 11 💬
|
| 271 | Rituximab Injection | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 11 11, 35, 222 💬
|
| 272 | RO 533-3787/F01-06 | - | - | - | - | [1] 11 11 💬
|
| 273 | RO5333787 | - | - | - | - | [2] 11 11, 13 💬
|
| 274 | ROZANOLIXIZUMAB | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬
| - | - | [3] 11 11, 14, 63 💬
|
| 275 | RVT-1401 | - | - | - | - | [3] 11 11, 14, 61 💬
|
| 276 | RVT-1401, HL161BKN, HBM9161 | - | - | - | - | [1] 11 11 💬
|
| 277 | Salbutamol | - | - | - | - | [9] 2 2, 3, 11, 85, 86, 228, 256, 299, 340 💬
|
| 278 | Salbutamol 4Mg Tablet | - | - | - | - | [1] 11 11 💬
|
| 279 | SALBUTAMOL SULFATE PH. EUR. | - | - | - | - | [1] 11 11 💬
|
| 280 | Salbutamol WZF 4 mg | - | - | - | - | [1] 11 11 💬
|
| 281 | SAR442168 | - | - | - | - | [2] 11 11, 13 💬
|
| 282 | SATRALIZUMAB | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [4] 11 11, 13, 86, 113 💬
|
| 283 | SHR-2173 injection | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 284 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [31] 2 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
|
| 285 | Sodium Chloride solution | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [4] 11 11, 13, 51, 228 💬
|
| 286 | SOLIRIS | - | - | - | - | [6] 11 11, 13, 14, 62, 109, 223 💬
|
| 287 | Standard Lymphodepletion regimen | - | - | - | - | [3] 11 11, 13, 51 💬
|
| 288 | Standard of Care Treatment | - | - | - | - | [6] 11 11, 49, 53, 96, 245, 246 💬
|
| 289 | Steroid Drug | - | - | - | - | [3] 11 11, 46, 49 💬
|
| 290 | Subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬
|
| 291 | Subcutaneous immunoglobulins | - | - | - | - | [1] 11 11 💬
|
| 292 | Sufentanil | [1] Sufentanil Sufentanil | [2] Sufentanil citrate
Sufentanil citrate
,
Sufentanil
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [5] 11 11, 22, 46, 70, 280 💬
|
| 293 | Sugammadex | [1] Sugammadex Sugammadex | [1] Sugammadex sodium
Sugammadex sodium
💬
| - | - | [1] 11 11 💬
|
| 294 | Sustained-Release Tablets | - | - | - | - | [1] 11 11 💬
|
| 295 | Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil) | [3] Azathioprine Azathioprine, Mycophenolate mofetil, Tacrolimus | [6] Tacrolimus
Tacrolimus
,
Azathioprine
,
Mycophenolate mofetil
,
Azathioprine sodium
,
Mycophenolate mofetil hydrochloride
,
Tacrolimus
💬
| [7] IMPDH1 IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [35] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 296 | Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg) | - | - | - | - | [1] 11 11 💬
|
| 297 | Syngeneic Bone Marrow Transplantation | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 298 | SYS6020 injection | - | - | - | - | [1] 11 11 💬
|
| 299 | T-peptide-CRM197 conjugate | - | - | - | - | [1] 11 11 💬
|
| 300 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 301 | Tacrolimus capsule | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 302 | TAK-079 | - | - | - | - | [3] 11 11, 49, 63 💬
|
| 303 | Talquetamab | [1] Talquetamab Talquetamab | [1] Talquetamab
Talquetamab
💬
| [1] CD3E CD3E 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 11 11, 28 💬
|
| 304 | Telitacicept | [1] Telitacicept Telitacicept | - | - | - | [14] 11 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
|
| 305 | Telitacicept-only group | [1] Telitacicept Telitacicept | - | - | - | [1] 11 11 💬
|
| 306 | Tetanus vaccin | - | - | - | - | [1] 11 11 💬
|
| 307 | Thymectomy plus prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 11 11 💬
|
| 308 | Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [26] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
|
| 309 | Tocilizumab Injectable Product | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 11 11 💬
|
| 310 | Tocilizumab Injection | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 11 11, 13 💬
|
| 311 | Tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [23] 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 312 | Tofacitinib 5 MG | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [5] 11 11, 40, 46, 50, 271 💬
|
| 313 | Tolebrutinib | [1] Tolebrutinib Tolebrutinib | [1] Tolebrutinib
Tolebrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2] 11 11, 13 💬
|
| 314 | Tolebrutininb | - | - | - | - | [1] 11 11 💬
|
| 315 | UCAR T-cell | - | - | - | - | [7] 11 11, 13, 14, 49, 51, 66, 222 💬
|
| 316 | UCAR T-cell group | - | - | - | - | [3] 11 11, 49, 61 💬
|
| 317 | UCB7665 | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬
| - | - | [3] 11 11, 14, 63 💬
|
| 318 | Ultomiris | - | - | - | - | [7] 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 319 | Ultomiris 1,100 mg/11 mL | - | - | - | - | [1] 11 11 💬
|
| 320 | Universal allogeneic anti-CD19/BCMA CAR T-cells | - | - | - | - | [4] 11 11, 49, 51, 61 💬
|
| 321 | Universal BCMA CAR-T | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 322 | Universal CD19 CAR-?dT Cell Injection | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 323 | Universal CD19 CAR-T | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 324 | Uplizna | - | - | - | - | [3] 11 11, 13, 300 💬
|
| 325 | Velamox | - | - | - | - | [1] 11 11 💬
|
| 326 | Velcade® | - | - | - | - | [1] 11 11 💬
|
| 327 | Zilbrysq | - | - | - | - | [1] 11 11 💬
|
| 328 | Zilucoplan | [1] Zilucoplan Zilucoplan | [2] Zilucoplan sodium
Zilucoplan sodium
,
Zilucoplan
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 2 2, 11, 62 💬
|
| 329 | Zilucoplan (RA101495) | [1] Zilucoplan Zilucoplan | [2] Zilucoplan sodium
Zilucoplan sodium
,
Zilucoplan
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 11 11, 62 💬
|
| 330 | Zilucoplan® | [1] Zilucoplan Zilucoplan | [2] Zilucoplan sodium
Zilucoplan sodium
,
Zilucoplan
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬
|